Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.795 USD | +4.29% | +15.50% | -60.96% |
Mar. 28 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 05 | Top Midday Gainers | MT |
Financials (USD)
Sales 2024 * | 59.17M | Sales 2025 * | 88.09M | Capitalization | 36.31M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 11M | EV / Sales 2024 * | 0.61 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.41 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
8.22
x | Employees | 176 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.99% |
1 day | +4.29% | ||
1 week | +15.50% | ||
Current month | +18.73% | ||
1 month | -15.56% | ||
3 months | -55.56% | ||
6 months | -41.16% | ||
Current year | -60.96% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Wu He
CEO | Chief Executive Officer | 59 | 19-04-01 |
Wei Zhang
DFI | Director of Finance/CFO | 64 | 18-08-31 |
Chun Hua Wang
COO | Chief Operating Officer | 52 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Wu He
CEO | Chief Executive Officer | 59 | 19-04-01 |
Yue Wu
BRD | Director/Board Member | 62 | 13-03-31 |
Zhen Bo Su
BRD | Director/Board Member | 48 | 23-03-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 2.795 | +4.29% | 9,536 |
24-05-02 | 2.68 | +12.13% | 14,627 |
24-05-01 | 2.39 | +1.53% | 5,733 |
24-04-30 | 2.354 | +0.60% | 5,734 |
24-04-29 | 2.34 | -3.31% | 4,184 |
Delayed Quote Nasdaq, May 03, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-60.96% | 36.31M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- CASI Stock